Medicalpark Izmir Hospital

Izmir 35575

0 studies enrolling now · 2 studies all time

What they study most

ACUTE LYMPHOBLASTIC LEUKEMIA, Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Leukemia, Precursor b-Cell Lymphoblastic Leukemia-Lymphoma

Studies at this site

• A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma — Running, not enrolling
• A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients — Completed